Kenvue Inc. Common Stock vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.47 (market cap $28.50B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| KVUE | LQD | |
|---|---|---|
Market Cap | $34.06B | $28.50B |
Volume | 23,267,228 | 37,320,110 |
Sector | Consumer Staples | Fixed Income |
52-Week High | $19.83 | $112.91 |
52-Week Low | $14.11 | $101.83 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 125 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LQD trades at $102.41 with a slight 0.28% daily gain amid a challenging bond market environment. The ETF shows bearish technical signals with moving averages indicating selling pressure, though oscillators remain neutral. Recent news highlights significant short interest growth of 53.1% in September and concerns about investment-grade corporate bonds as Treasury yields hit multi-decade highs. The fund maintains consistent dividend distributions with recent payouts around $0.44-0.46 per share.
The outlook remains cautious given the bearish technical setup and rising bond yields pressuring corporate debt valuations. Key risks include continued bond market volatility and higher borrowing costs for issuers. Investment opportunities exist for income-focused investors seeking exposure to investment-grade corporate bonds, though near-term price pressure may persist until bond market conditions stabilize.
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →